Pankeia has been included the the Top 22 Rising Start ups Applying Artificial Intelligence in Cancer

Aug 18, 2022
1 min read

The Omdena “Impact Tech Start ups Series” is comprised of game-changing start ups, stories, and thought-leadership pieces from leading impact ventures solving real-world problems. Thank you for the recognition and congratulations to our peers who are included the list. Read more...

Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for

Panakeia to attend and present at upcoming scientific and business conferences

Cambridge, UK, 16 April 2026 – Panakeia (“the Company”), the world’s first in silico multi-omics company, is pleased to confirm that it will be attending and presenting at a number of conferences in

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer

· Largest real-world, blinded, multi-site validation of AI molecular profiling from routine diagnostic images · Software identifies clinically actionable cancer biomarkers in minutes rathe